(Q38865264)

English

Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime

scientific article published on January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

lipopolysaccharide

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

Akiyama M

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Oishi K

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Tao M

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Matsumoto K

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Pollack M

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

629-635

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Hypersusceptibility of penicillin-treated group B streptococci to bactericidal activity of human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Hospital-acquired gram-negative rod pneumonias: an overview.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Antibacterial and Protective Properties of Monoclonal Antibodies Reactive with Escherichia coli O111:B4 Lipopolysaccharide: Relation to Antibody Isotype and Complement-Fixing Activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Use of third-generation cephalosporins. Pseudomonas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02543.X

21 January 2018

Identifiers

10.1111/J.1348-0421.2000.TB02543.X

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38865264&oldid=1794534511"